The potential curative and hepatoprotective effects of platelet rich plasma on liver fibrosis in Schistosoma mansoni experimentally infected mice

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Bayoumi A.M.A.; Ismail M.A.M.; Mahmoud S.S.; Soliman A.S.A.; Mousa A.M.A.; Yousof H.-A.S.A.

Journal: Journal of Parasitic Diseases

Publisher: Springer

Publication Date: 3 April 2023

Volume / Issue: Volume 47 / Issue 2

Pages: 349–362

ISSN: 9717196

DOI: 10.1007/s12639-023-01576-9

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Green Open Access


Authors and Affiliations

Bayoumi A.M.A., Medical Parasitology Department, Faculty of Medicine, Damietta University, Damietta, Egypt; Ismail M.A.M., Medical Parasitology Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Kasr Al-Ainy St, Cairo, 11562, Egypt; Mahmoud S.S., Parasitology Department, Theodor Bilharz Research Institute, Imbaba, Giza, Egypt; Soliman A.S.A., Pathology Department, National Research Centre, Cairo, Egypt; Mousa A.M.A., Pathology Department, Faculty of Medicine, October 6 University, 6th of October City, Egypt; Yousof H.-A.S.A., Medical Parasitology Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Kasr Al-Ainy St, Cairo, 11562, Egypt


Abstract

Trapped Schistosoma mansoni eggs trigger fibrotic liver disease that can continue to liver cirrhosis and failure. This work evaluates the outcome of platelet rich plasma (PRP) on S. mansoni-induced liver fibrosis by intraperitoneal (IP) and intrahepatic (IH) routes with/without Praziquantel (PZQ) treatment. Swiss albino mice (n = 162) were divided into non-infected (n = 66) and infected (n = 96) groups, then subdivided into non-treated and treated subgroups with PRP(IP), PRP(IH) 6th and 10th weeks post-infection, PZQ, PZQ + PRP(IP) and PZQ + PRP(IH) 6th and 10th weeks post-infection. Effects of treatments were evaluated by parasitological, histopathological and Immunohistochemical assessments. In the early assessment (12th week post-infection) of infected-treated groups, the mean granuloma number showed significant reduction in groups treated with PZQ + PRP (IH) 10th week, PRP (IP), PZQ + PRP (IP) and PZQ + PRP (IH) 6th week (33.33%, 33%, 27.77% and 27.22%, respectively). Furthermore, the mean granuloma diameter showed significant reduction in groups treated with PRP (IH) 10th week and PZQ + PRP (IP) (24.17% and 15.5%, respectively). Also, the fibrotic index showed significant reduction in groups treated with PZQ + PRP (IP), PRP (IP) and PZQ + PRP (IH) 6th week (48.18%, 46.81% and 41.36%, respectively). Transforming growth factor β1(TGF-β1) expression was in correlation with parasitological and histopathological results. Diminished TGF-β1 expression was mostly in infected groups treated with PZQ + PRP (IP), PZQ + PRP (IH) 6th week and PRP (IP) (88.63%, 88.63% and 77.27%, respectively). In the late assessment (14th week post-infection) of infected treated groups, TGF-β1expression was reduced in groups treated with PZQ, PRP (IH) 10th weeks, PRP (IP) (83.33%, 66.66%, 33.33% respectively). PRP showed promising anti-fibrotic effects on S. mansoni-induced liver fibrosis. © 2023, Indian Society for Parasitology.


Keywords

Liver fibrosis; Platelet rich plasma (PRP); Praziquantel (PZQ); Schistosoma mansoni; Transforming growth factor-β1 (TGF-β1); cremophor; heparin; praziquantel; thiopental; transforming growth factor beta1; animal experiment; animal model; animal tissue; Article; controlled study; granuloma; histopathology; immunohistochemistry; liver protection; liver sinusoid; male; mouse; nonhuman; outcome assessment; parasitology; protein expression; thrombocyte rich plasma


Citation Information

Scopus Citations: 6


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]